| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 1, 2025 | Aug 5, 2025 | Verona Pharma plc | CEO | Sell | 40.0 | -208,912 | -1.54% | ✓ | $2.7M |
| Jul 7, 2025 | Jul 9, 2025 | Verona Pharma plc | CEO | Sell | 40.0 | -90,320 | -0.67% | ✗ | $1M |
| Jun 11, 2025 | Jun 13, 2025 | Verona Pharma plc | CEO | Sell | 36.3 | -400,000 | -2.94% | ✓ | $4.6M |
| May 27, 2025 | May 29, 2025 | Verona Pharma plc | CEO | Sell | 36.3 | -400,000 | -2.86% | ✓ | $3.7M |
| May 1, 2025 | May 5, 2025 | Verona Pharma plc | CEO | Sell | 38.8 | -587,008 | -1.36% | ✓ | $5.3M |
| Apr 29, 2025 | May 1, 2025 | Verona Pharma plc | CEO | Sell | 45.0 | -90,360 | -0.62% | ✓ | $811.4K |
| Feb 1, 2025 | Feb 4, 2025 | Verona Pharma plc | CEO | Sell | 70.0 | +33,272 | 0.23% | ✗ | $1.2M |
| Dec 4, 2024 | Dec 6, 2024 | Verona Pharma plc | CEO | Sell | 27.5 | -870,672 | -5.78% | ✓ | $4.4M |
| Nov 27, 2024 | Dec 2, 2024 | Verona Pharma plc | CEO | Sell | 45.0 | -125,328 | -0.82% | ✓ | $627.2K |
| Nov 25, 2024 | Nov 26, 2024 | Verona Pharma plc | CEO | Sell | 58.8 | -1,600 | -0.01% | ✓ | $8K |
| Nov 11, 2024 | Nov 13, 2024 | Verona Pharma plc | CEO | Sell | 57.5 | -2,400 | -0.02% | ✓ | $12K |
| Nov 1, 2024 | Nov 5, 2024 | Verona Pharma plc | CEO | Sell | 45.0 | -141,032 | -0.92% | ✓ | $618.7K |
| Oct 30, 2024 | Nov 1, 2024 | Verona Pharma plc | CEO | Sell | 95.0 | +754,048 | 5.17% | ✗ | $1M |
| Oct 23, 2024 | Oct 25, 2024 | Verona Pharma plc | CEO | Sell | 45.0 | -144,816 | -0.98% | ✓ | $633.9K |
| Oct 18, 2024 | Oct 22, 2024 | Verona Pharma plc | CEO | Sell | 32.5 | -514,152 | -3.37% | ✓ | $2.3M |
| Sep 11, 2024 | Sep 13, 2024 | Verona Pharma plc | CEO | Sell | 32.5 | -600,000 | -3.79% | ✓ | $2.3M |
| Aug 12, 2024 | Aug 14, 2024 | Verona Pharma plc | CEO | Sell | 36.3 | -400,000 | -2.46% | ✓ | $1.3M |
| Aug 7, 2024 | Aug 9, 2024 | Verona Pharma plc | CEO | Sell | 90.0 | +485,200 | 3.08% | ✗ | $824.8K |
| Aug 1, 2024 | Aug 5, 2024 | Verona Pharma plc | CEO | Sell | 42.5 | -88,544 | -0.56% | ✗ | $250.8K |
| May 1, 2024 | May 3, 2024 | Verona Pharma plc | CEO | Sell | 45.0 | -88,544 | -0.56% | ✗ | $171K |
| Feb 1, 2024 | Feb 5, 2024 | Verona Pharma plc | CEO | Sell | 37.5 | -480,200 | -2.92% | ✗ | $1.1M |
| Nov 1, 2023 | Nov 3, 2023 | Verona Pharma plc | CEO | Sell | 37.5 | -809,008 | -4.69% | ✗ | $1.4M |
| Aug 3, 2023 | Aug 7, 2023 | Verona Pharma plc | CEO | Sell | 42.5 | -275,888 | -1.65% | ✓ | $693.9K |
| Aug 1, 2023 | Aug 3, 2023 | Verona Pharma plc | CEO | Sell | 42.5 | -179,648 | -1.06% | ✓ | $474.9K |
| May 1, 2023 | May 3, 2023 | Verona Pharma plc | CEO | Sell | 36.3 | -455,536 | -2.63% | ✓ | $1.2M |
| Feb 1, 2023 | Feb 3, 2023 | Verona Pharma plc | CEO | Sell | 36.3 | -432,928 | -2.44% | ✓ | $1.1M |
| Dec 20, 2022 | Dec 21, 2022 | Verona Pharma plc | CEO | Sell | 32.5 | -600,000 | -3.27% | ✓ | $1.3M |
| Nov 1, 2022 | Nov 3, 2022 | Verona Pharma plc | CEO | Sell | 38.8 | -487,760 | -2.59% | ✓ | $782.8K |
| Aug 9, 2022 | Aug 11, 2022 | Verona Pharma plc | CEO | Sell | 32.5 | -600,000 | -3.78% | ✓ | $1.1M |
| Aug 1, 2022 | Aug 3, 2022 | Verona Pharma plc | CEO | Sell | 38.8 | -487,768 | -2.98% | ✓ | $328.9K |
| May 3, 2022 | May 5, 2022 | Verona Pharma plc | CEO | Sell | 53.8 | -32,904 | -0.20% | ✓ | $16.3K |
| May 1, 2022 | May 3, 2022 | Verona Pharma plc | CEO | Sell | 42.5 | -454,864 | -2.70% | ✗ | $237.7K |
| Feb 1, 2022 | Feb 3, 2022 | Verona Pharma plc | CEO | Sell | 51.3 | -6,256 | -0.04% | ✓ | $261.8K |
| Nov 1, 2021 | Nov 3, 2021 | Verona Pharma plc | CEO | Sell | 38.8 | -506,904 | -2.92% | ✓ | $324.5K |
| Aug 3, 2021 | Aug 9, 2021 | Verona Pharma plc | CEO | Sell | 53.8 | -17,656 | -0.10% | ✓ | $13.3K |
| Aug 1, 2021 | Aug 4, 2021 | Verona Pharma plc | CEO | Sell | 38.8 | -489,248 | -2.74% | ✓ | $382.9K |
| May 3, 2021 | May 5, 2021 | Verona Pharma plc | CEO | Sell | 20.0 | -2,191,688 | -10.93% | ✓ | $1.9M |
| Mar 1, 2021 | Mar 3, 2021 | Verona Pharma plc | CEO | Sell | 53.8 | -43,392 | -0.22% | ✓ | $49.6K |